Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease
Hachana, Mohamed Ridha ; Université de Liège - ULiège > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén.
Korbi, Sadok
Language :
English
Title :
Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease
Ferlay J., Bray F., Pisani P., and Parkin D.M. Globocan 2000: cancer incidence, mortality and prevalence worldwide (2001), IARC Press, Lyon
Huang D.P., and LO K.W. Aetiological factors and pathogenesis. In: Van Hasselt G.A., and Gibb A.G. (Eds). Nasopharyngeal carcinoma (1999), The Chinese University Press, Hong kong 31-60
Lo K.W., Tsao S.W., Leung S.F., Choi P.H.K., Lee J.C.K., and Huang D.P. Detailed deletion mapping on the short arm of chromosome 3 in nasopharyngeal carcinomas. Int J Oncol 4 (1994) 1359-1364
Sung N.S., Zeng Y., and Raab-Traub N. Alterations on chromosome 3 in endemic and nonendemic nasopharyngeal carcinoma. Int J Cancer 86 (2000) 244-250
Hu L.F., Eiriksdottir G., Lebedeva T., Kholodniouk I., Alimov A., Chen F., et al. Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma. Genes Chromosomes Cancer 17 (1996) 118-126
Huang D.P., Lo K.W., van Hasselt C.A., Woo J.K., Choi P.H., Leung S.F., et al. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 54 (1994) 4003-4006
Hui A.B., Lo K.W., Leung S.F., Choi P.H., Fong Y., Lee J.C., et al. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res 56 (1996) 3225-3229
Tsang Y.S., Lo K.W., Leung S.F., Choi P.H., Fong Y., Lee J.C., et al. Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int J Cancer 83 (1999) 305-308
Mutirangura A., Pornthanakasem W., Sriuranpong V., Supiyaphun P., and Voravud N. Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma. Int J Cancer 78 (1998) 153-156
Chan A.S., To K.F., Lo K.W., Mak K.F., Pak W., Chiu B., et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 60 (2000) 5365-5370
Spano J.P., Busson P., Atlan D., Bourhis J., Pignon J.P., Esteban C., and Armand J.P. Nasopharyngeal carcinomas: an update. Eur J Cancer 39 (2003) 2121-2135
Braham H., Trimeche M., Ziadi S., Mestiri S., Mokni M., Amara K., et al. CD10 expression by fusiform stromal cells in nasopharyngeal carcinoma correlates with tumor progression. Virchows Arch 449 (2006) 220-224
In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). World health organization classification of tumours. Pathology and genetics of head and neck tumours (2005), IARC Press, Lyon
Trimeche M., Ziadi S., de Leval L., Hmissa S., Sriha B., Mokni M., et al. Prevalence of Epstein-Barr virus in non-Hodgkin's lymphomas in central region of Tunisia. Ann Pathol 25 (2005) 95-102
Zhuang Z., Bertheau P., Emmert-Buck M.R., Liotta L.A., Gnarra J., Linehan W.M., et al. A microdissection technique for archival DNA analysis of specific cell populations in lesions <1 mm in size. Am J Pathol 146 (1995) 620-625
Deng L., Jing N., Tan G., Zhou M., Zhan F., Xie Y., et al. A common region of allelic loss on chromosome region 3p25.3-26.3 in nasopharyngeal carcinoma. Genes Chromosomes Cancer 23 (1998) 21-25
Hu L.F., Eiriksdottir G., Lebedeva T., Kholodniouk I., Alimov A., Chen F., et al. Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma. Genes Chromosomes Cancer 17 (1996) 118-126
Xiong W., Zeng Z.Y., Xia J.H., Xia K., Shen S.R., Li X.L., et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 64 (2004) 1972-1974
Bocker T., Diermann J., Friedl W., Gebert J., Holinski-Feder E., Karner-Hanusch J., et al. Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res 57 (1997) 4739-4743
Dasgupta S., Chakraborty S.B., Roy A., Roychowdhury S., and Panda C.K. Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients. Mol Pathol 56 (2003) 263-269
Dasgupta S., Mukherjee N., Roy S., Roy A., Sengupta A., Roychowdhury S., et al. Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population. Oral Oncol 38 (2002) 6-15
Hollander M.C., Philburn R.T., Patterson A.D., Velasco-Miguel S., Friedberg E.C., Linnoila R.I., et al. Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc Natl Acad Sci USA 102 (2005) 13200-13205
Arcand S.L., Provencher D., Mes-Masson A.M., and Tonin P.N. OGG1 Cys326 variant, allelic imbalance of chromosome band 3p25.3 and TP53 mutations in ovarian cancer. Int J Oncol 27 (2005) 315-320
Hansen R., Saebo M., Skjelbred C.F., Nexo B.A., Hagen P.C., Bock G., et al. GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett 229 (2005) 85-91
Wang Z., Mandell K.J., Parkos C.A., Mrsny R.J., and Nusrat A. The second loop of occludin is required for suppression of Raf1-induced tumor growth. Oncogene 24 (2005) 4412-4420
Lo K.W., Teo P.M., Hui A.B., To K.F., Tsang Y.S., Chan S.Y., et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 60 (2000) 3348-3353
Cheng Y., Poulos N.E., Lung M.L., Hampton G., Ou B., Lerman M.I., et al. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci USA 95 (1998) 3042-3047
Arai K., Shibahara T., Yamamoto N., and Noma H. The presence of candidate tumor suppressor gene loci at chromosome 3p for oral squamous cell carcinomas. Oral Oncol 38 (2002) 763-771
Braga E.A., Kashuba V.I., Maliukova A.V., Loginov V.I., Senchenko V.N., Bazov I.V., et al. New tumor suppressor genes in hot spots of human chromosome 3: new methods of identification. Mol Biol 37 (2003) 194-211
Wang L., Darling J., Zhang J.S., Liu W., Qian J., Bostwick D., et al. Loss of expression of the DRR 1 gene at chromosomal segment 3p21.1 in renal cell carcinoma. Genes Chromosomes Cancer 27 (2000) 1-10
Satoshi M., Fujio K., Goi S., Masahiko O., Yusuke N., and Mitsuru E. Detailed deletion mapping of chromosome arm 3p in breast cancers: A 2-cM region on 3p14.3-21.1 and a 5 cM region on 3p24.3-25.1 commonly deleted in tumors. Genes chromosomes Cancer 20 (1997) 268-274
Kashuba V.I., Szeles A., Allikmets R., Nilsson A.S., Bergerheim U.S., Modi W., et al. A group of NotI jumping and linking clones cover 2.5 Mb in the 3p21-p22 region suspected to contain a tumor suppressor gene. Cancer Genet Cytogenet 81 (1995) 144-150
Protopopov A., Kashuba V., Zabarovska V.I., Muravenko O.V., Lerman M.I., Klein G., et al. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res 60 (2000) 6116-6133
Lerman M.I., Minna J., Sekido Y., Bader S., Burbee D., Fong K., et al. The 630-Kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. Cancer Res 60 (2000) 6116-6133
Sriuranpong V., Mutirangura A., Gillespie J.W., Patel V., Amornphimoltham P., Molinolo A.A., et al. Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. Clin Cancer Res 10 (2004) 4944-4958
Jensen D.E., Proctor M., Marquis S.T., Gardner H.P., Ha S.I., Chodosh L.A., et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16 (1998) 1097-1112
Zeng Z., Zhou Y., Zhang W., Li X., Xiong W., Liu H., et al. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med 3 (2006) 156-160
Huang D.P., Lo K.W., Choi P.H., Ng A.Y., Tsao S.Y., Yiu G.K., et al. Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet Cytogenet 54 (1991) 91-99
Khabir A., Ghorbel A., Daoud J., Frikha M., Drira M.M., Laplanche A., Busson P., et al. Similar BCL-X but different BCL-2 levels in the two age groups of North African nasopharyngeal carcinomas. Cancer Detect Prev 27 (2003) 250-255
Khabir A., Karray H., and Rodriguez S. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas. J Virol 2 (2005) 39-46
Karray H., Ayadi W., Fki L., Hammami A., Daoud J., Drira M.M., et al. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia. J Med Virol 75 (2005) 593-602
Harn H.J., Fan H.C., Chen C.J., Tsai N.M., Yen C.Y., and Huang S.C. Microsatellite alteration at chromosome 11 in primary human nasopharyngeal carcinoma in Taiwan. Oral Oncol 38 (2002) 23-29
Wong T.S., Kwong D.L., Sham J.S., Wei W.I., Kwong Y.L., and Yuen A.P. Quantitative plasma hypermethylated DNA markers of undifferentiated nasopharyngeal carcinoma. Clin Cancer Res 10 (2004) 2401-2406
Wong T.S., Tang K.C., Kwong D.L., Sham J.S., Wei W.I., Kwong Y.L., and Yuen A.P. Differential gene methylation in undifferentiated nasopharyngeal carcinoma. Int J Oncol 22 (2003) 869-874
Tan S.H., Ida H., Goh B.C., Hsieh W., Loh M., and Ito Y. Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma. Anticancer Res 26 (2006) 4287-4292
Sckolnick J., Murphy J., and Hunt J.L. Microsatellite instability in nasopharyngeal and lymphoepithelial carcinomas of the head and neck. Am J Surg Pathol 30 (2006) 1250-1253
Tsai C.N., Tsai C.L., Tse K.P., Chang H.Y., and Chang Y.S. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA 99 (2002) 10084-10089
